Requintosa, Mary Aphfe .

HRN: 26-56-52  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/24/2025
CEFUROXIME 1.5GM (VIAL)
03/24/2025
03/30/2025
IV
1.5g
PTOR
Pre Op Prophylaxis
Waiting Final Action 
03/25/2025
CLINDAMYCIN 300MG (CAP)
03/25/2025
04/01/2025
ORAL
300mg
TID
S/P Endometrial Biopsy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: